Bitcoin halving
What does that mean?
$2.78T
Total marketcap
$105.92B
Total volume
BTC 49.58%     ETH 15.30%
Dominance

Amicus Therapeutics FOLD Stock

11.78 USD {{ price }} -0.674536% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
3.48B USD
LOW - HIGH [24H]
11.49 - 11.93 USD
VOLUME [24H]
2.4M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.51 USD

Amicus Therapeutics Price Chart

Amicus Therapeutics FOLD Financial and Trading Overview

Amicus Therapeutics stock price 11.78 USD
Previous Close 13.3 USD
Open 13.29 USD
Bid 0 USD x 3200
Ask 0 USD x 800
Day's Range 12.83 - 13.36 USD
52 Week Range 8.48 - 13.84 USD
Volume 2.86M USD
Avg. Volume 2.6M USD
Market Cap 3.69B USD
Beta (5Y Monthly) 0.797183
PE Ratio (TTM) N/A
EPS (TTM) -0.51 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 15.8 USD

FOLD Valuation Measures

Enterprise Value 3.89B USD
Trailing P/E N/A
Forward P/E 92.57143
PEG Ratio (5 yr expected) 0.19
Price/Sales (ttm) 10.950821
Price/Book (mrq) 35.801105
Enterprise Value/Revenue 11.542
Enterprise Value/EBITDA -23.317

Trading Information

Amicus Therapeutics Stock Price History

Beta (5Y Monthly) 0.797183
52-Week Change 38.60%
S&P500 52-Week Change 20.43%
52 Week High 13.84 USD
52 Week Low 8.48 USD
50-Day Moving Average 11.76 USD
200-Day Moving Average 11.66 USD

FOLD Share Statistics

Avg. Volume (3 month) 2.6M USD
Avg. Daily Volume (10-Days) 3.15M USD
Shares Outstanding 284.58M
Float 208.4M
Short Ratio 5.99
% Held by Insiders 0.86%
% Held by Institutions 105.76%
Shares Short 19.12M
Short % of Float 6.75%
Short % of Shares Outstanding 6.71%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -60.64%
Operating Margin (ttm) -51.041%
Gross Margin 88.72%
EBITDA Margin -49.50%

Management Effectiveness

Return on Assets (ttm) -14.066%
Return on Equity (ttm) -119.72%

Income Statement

Revenue (ttm) 336.79M USD
Revenue Per Share (ttm) 1.16 USD
Quarterly Revenue Growth (yoy) 9.59%
Gross Profit (ttm) 290.63M USD
EBITDA -166712000 USD
Net Income Avi to Common (ttm) -204240000 USD
Diluted EPS (ttm) -0.7
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 267.11M USD
Total Cash Per Share (mrq) 0.94 USD
Total Debt (mrq) 452.01M USD
Total Debt/Equity (mrq) 440.67 USD
Current Ratio (mrq) 2.888
Book Value Per Share (mrq) 0.362

Cash Flow Statement

Operating Cash Flow (ttm) -126329000 USD
Levered Free Cash Flow (ttm) -66124500 USD

Profile of Amicus Therapeutics

Country United States
State PA
City Philadelphia
Address 3675 Market Street
ZIP 19104
Phone 215 921 7600
Website https://amicusrx.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 484

Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.

Q&A For Amicus Therapeutics Stock

What is a current FOLD stock price?

Amicus Therapeutics FOLD stock price today per share is 11.78 USD.

How to purchase Amicus Therapeutics stock?

You can buy FOLD shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Amicus Therapeutics?

The stock symbol or ticker of Amicus Therapeutics is FOLD.

Which industry does the Amicus Therapeutics company belong to?

The Amicus Therapeutics industry is Biotechnology.

How many shares does Amicus Therapeutics have in circulation?

The max supply of Amicus Therapeutics shares is 295.38M.

What is Amicus Therapeutics Price to Earnings Ratio (PE Ratio)?

Amicus Therapeutics PE Ratio is now.

What was Amicus Therapeutics earnings per share over the trailing 12 months (TTM)?

Amicus Therapeutics EPS is -0.51 USD over the trailing 12 months.

Which sector does the Amicus Therapeutics company belong to?

The Amicus Therapeutics sector is Healthcare.

Amicus Therapeutics FOLD included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16379.46 USD
-0.12
4.79B USD 16347.38 USD 16420.92 USD 4.79B USD
NASDAQ Biotechnology Total Retu XNBI 4753.69 USD
-0.36
4750.07 USD 4787.94 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2184.32 USD
+0.6
2175.22 USD 2195.28 USD
NASDAQ Global Market Composite NQGM 2283.98 USD
+0.52
2277.12 USD 2296.84 USD
Stlmt ID NASDAQ Biotechnology NBX 4604.4 USD
-2.98
4555.41 USD 4917.8 USD
NASDAQ Composite Total Return I XCMP 19904.22 USD
-0.12
19865.24 USD 19954.6 USD
Nasdaq US Smart Pharmaceuticals NQSSPH 1486.34 USD
+0.05
1484.78 USD 1491.97 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2657.07 USD
+0.1
2653.57 USD 2668.1 USD
NASDAQ Biotechnology NBI 4429.97 USD
-0.36
4426.59 USD 4461.88 USD
NASDAQ HealthCare IXHC 1011.84 USD
-0.04
1011.35 USD 1017.55 USD